How are TCF7L2 and menopause related?

TCF7L2 is a transcription factor involved in Wnt signaling and strongly associated with type 2 diabetes risk. Menopause involves a sharp decline in estrogen and progesterone, which alters glucose metabolism and insulin sensitivity. A direct causal relationship between TCF7L2 variants and menopause timing or symptoms is not established in the literature. Some studies suggest that TCF7L2 polymorphisms may indirectly modulate metabolic changes during postmenopause via insulin secretion and lipid metabolism, but the evidence is weak and based on small-effect GWAS associations. Consumer DNA tests often overstate such links. No robust clinical recommendations can be derived. Lifestyle interventions for menopause should follow evidence-based guidelines, not genetic variants. The interaction between TCF7L2 and menopause remains an area of preliminary research with unclear translational value.